Skip to main content
. 2020 Nov 3;34(6):3375–3385. doi: 10.21873/invivo.12176

Table IV. Programmed cell death-ligand 1 (PD-L1) expression according to the lung neuroendocrine tumor subtype.

graphic file with name in_vivo-34-3382-i0001.jpg

LCNEC: Large-cell neuroendocrine carcinoma; SCLC: small-cell lung carcinoma; TPS: tumor proportion score. *PD-L1 positivity was defined as TPS ≥1%